Research has shown that it can: Reduce inflammation in the gut lining Support the integrity of the intestinal barrier (preventing leaky gut) Accelerate repair of intestinal tissues damaged by inflammation, ulcers, or injury Enhance blood flow to compromised GI areas, promoting faster regeneration These mechanisms are highly relevant for patients with diverticulitis, where inflammation and tissue breakdown are at the heart of the issue
While these remedies can be effective for mild cases, it is essential to monitor symptoms closely
It has no licensed medical indication in the UK
A provider can help review: Whether BPC-157 is appropriate for your situation Whether another peptide or regenerative option may be safer Possible medication or health-history concerns Route of use and cycle length Sterility and sourcing concerns Whether follow-up monitoring is needed When to stop, pause, or adjust the plan Medical guidance matters because peptide therapy should be personalized, monitored, and tied to a real treatment goal
What was BPC-157 used for